⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16347063 | 0.82 | — | — | |
| SCHEMBL7099908 | 0.76 | — | — | |
| SCHEMBL10401726 | 0.74 | APP (0.33) | — | |
| SCHEMBL2362181 | 0.74 | — | — | |
| SCHEMBL1156796 | 0.74 | — | — | |
| SCHEMBL1126808 | 0.74 | — | — | |
| SCHEMBL18277315 | 0.74 | — | — | |
| SCHEMBL9918800 | 0.74 | — | — | |
| SCHEMBL3415353 | 0.74 | — | — | |
| SCHEMBL5917879 | 0.74 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 20 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117779011-B | Wafer electroless tungsten plating alloy solution, preparation method and electroless tungsten plating method | 昆山一鼎工业科技有限公司 | 2024-05-14 | — | — | CN | disclosed |
| CN-117779011-A | Wafer electroless tungsten plating alloy solution, preparation method and electroless tungsten plating method | 昆山一鼎工业科技有限公司 | 2024-03-29 | — | — | CN | disclosed |
| US-20220340893-A1 | BI-FUNCTIONAL COMPLEXES AND METHODS FOR MAKING AND USING SUCH COMPLEXES | NUEVOLUTION A/S (DK) | 2022-10-27 | — | — | US | disclosed |
| EP-3929187-A2 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2021-12-29 | — | — | EP | disclosed |
| US-10844011-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2020-11-24 | — | — | US | disclosed |
| EP-3241826-B1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICALS CO (JP) | 2019-10-30 | — | — | EP | disclosed |
| CN-110229333-A | A kind of synthetic method of new type polyimide | 湘潭大学 | 2019-09-13 | — | — | CN | disclosed |
| CN-106349144-B | A kind of preparation method of (S)-oxiracetam intermediate | 山东默得森生物制药有限公司 | 2019-05-24 | — | — | CN | disclosed |
| US-20190127324-A1 | 5-ARYL-1H-PYRROLE-3-CARBONITRILE AND A PHARMACEUTICAL PRODUCT USING THE SAME | TAKEDA PHARMACEUTICALS CO (JP) | 2019-05-02 | — | — | US | disclosed |
| US-10173977-B2 | 5-aryl-1H-pyrrole-3-carbonitrile and a pharmaceutical product using the same | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2019-01-08 | — | — | US | disclosed |
| EP-2765130-B1 | Intermediates for use in a process of producing pyrrole compounds | TAKEDA PHARMACEUTICALS CO (JP) | 2017-07-26 | — | — | EP | disclosed |
| CN-106349144-A | Preparation method of (S)-oxiracetam intermediate | 山东默得森生物制药有限公司 | 2017-01-25 | — | — | CN | disclosed |
| EP-2402313-B1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL (JP) | 2016-08-24 | — | — | EP | disclosed |
| US-9266831-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2016-02-23 | — | — | US | disclosed |
| US-20140303378-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL (JP) | 2014-10-09 | — | — | US | disclosed |
| US-8822694-B2 | Process for producing pyrrole compound | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2014-09-02 | — | — | US | disclosed |
| EP-2765130-A2 | Process for producing pyrrole compound | Takeda Pharmaceutical Company Limited (JP) | 2014-08-13 | — | — | EP | disclosed |
| EP-2402313-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | Takeda Pharmaceutical Company Limited (JP) | 2012-01-04 | — | — | EP | disclosed |
| US-20110306769-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) | 2011-12-15 | — | — | US | disclosed |
| WO-2010098351-A1 | PROCESS FOR PRODUCING PYRROLE COMPOUND | 武田薬品工業株式会社 (JP) | 2010-09-02 | — | — | WO | disclosed |